ONCOMED PHARMACEUTICALS
OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment, by developing monoclonal antibodies that target the biologic pathways critical to tumor initiating cells, also known as รขโฌลcancer stem cellsรขโฌย. They are leveraging their understanding of these tumor initiating cells to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer.
ONCOMED PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2004-08-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.oncomed.com
Total Employee:
51+
Status:
Active
Contact:
650-995-8200
Email Addresses:
[email protected]
Total Funding:
210.15 M USD
Technology used in webpage:
SPF LetsEncrypt Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Amazon Route 53 DigiCert SSL Pound Sterling Amazon SSL GoDaddy
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Pharmagap Inc.
Pharmagap is a company that develops therapeutic drugs for the treatment of cancer.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Vencerx Therapeutic
Vencerx Therapeutics is a biotechnology company developing targeted therapeutics for the autism spectrum
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Morgenthaler Ventures
Morgenthaler Ventures investment in Series B - OncoMed Pharmaceuticals
Phase4 Ventures
Phase4 Ventures investment in Series B - OncoMed Pharmaceuticals
The Vertical Group
The Vertical Group investment in Series B - OncoMed Pharmaceuticals
U.S. Venture Partners
U.S. Venture Partners investment in Series B - OncoMed Pharmaceuticals
Delphi Ventures
Delphi Ventures investment in Series B - OncoMed Pharmaceuticals
Bay Partners
Bay Partners investment in Series B - OncoMed Pharmaceuticals
DeNovo Ventures
DeNovo Ventures investment in Series B - OncoMed Pharmaceuticals
Adams Street Partners
Adams Street Partners investment in Series B - OncoMed Pharmaceuticals
Latterell Venture Partners
Latterell Venture Partners investment in Series B - OncoMed Pharmaceuticals
Latterell Venture Partners
Latterell Venture Partners investment in Series A - OncoMed Pharmaceuticals
Official Site Inspections
http://www.oncomed.com
- Host name: 207.232.148.132.host.secureserver.net
- IP address: 132.148.232.207
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260